266 related articles for article (PubMed ID: 8709277)
1. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP
J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
[TBL] [Abstract][Full Text] [Related]
2. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.
Karlsson GB; Gao F; Robinson J; Hahn B; Sodroski J
J Virol; 1996 Sep; 70(9):6136-42. PubMed ID: 8709238
[TBL] [Abstract][Full Text] [Related]
3. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate.
Verrier FC; Charneau P; Altmeyer R; Laurent S; Borman AM; Girard M
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9326-31. PubMed ID: 9256481
[TBL] [Abstract][Full Text] [Related]
5. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection.
Freed EO; Martin MA
J Biol Chem; 1995 Oct; 270(41):23883-6. PubMed ID: 7592573
[No Abstract] [Full Text] [Related]
6. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
7. Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis.
Krüger U; Pfeiffer T; Bosch V
AIDS Res Hum Retroviruses; 1996 Jun; 12(9):783-92. PubMed ID: 8738430
[TBL] [Abstract][Full Text] [Related]
8. gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.
Marcon L; Sodroski J
J Virol; 1994 Mar; 68(3):1977-82. PubMed ID: 8107258
[TBL] [Abstract][Full Text] [Related]
9. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
Li YY; O'Donnell MA; Perez LG
Virology; 1996 Jan; 215(2):197-202. PubMed ID: 8560767
[TBL] [Abstract][Full Text] [Related]
11. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.
Cao J; Park IW; Cooper A; Sodroski J
J Virol; 1996 Mar; 70(3):1340-54. PubMed ID: 8627650
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay.
Huerta L; Lamoyi E; Báez-Saldaña A; Larralde C
Cytometry; 2002 Feb; 47(2):100-6. PubMed ID: 11813199
[TBL] [Abstract][Full Text] [Related]
15. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
Thali M; Furman C; Helseth E; Repke H; Sodroski J
J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
[TBL] [Abstract][Full Text] [Related]
17. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ; Baik SS; Doms RW
J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
[TBL] [Abstract][Full Text] [Related]
18. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
Alkhatib G; Broder CC; Berger EA
J Virol; 1996 Aug; 70(8):5487-94. PubMed ID: 8764060
[TBL] [Abstract][Full Text] [Related]
19. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
Dimitrov DS; Golding H; Blumenthal R
AIDS Res Hum Retroviruses; 1991 Oct; 7(10):799-805. PubMed ID: 1742075
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Gallo SA; Puri A; Blumenthal R
Biochemistry; 2001 Oct; 40(41):12231-6. PubMed ID: 11591141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
